» Articles » PMID: 36698403

Conditional Survival Analysis and Real-time Prognosis Prediction for Cervical Cancer Patients Below the Age of 65 Years

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jan 26
PMID 36698403
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Survival prediction for cervical cancer is usually based on its stage at diagnosis or a multivariate nomogram. However, few studies cared whether long-term survival improved after they survived for several years. Meanwhile, traditional survival analysis could not calculate this dynamic outcome. We aimed to assess the improvement of survival over time using conditional survival (CS) analysis and developed a novel conditional survival nomogram (CS-nomogram) to provide individualized and real-time prognostic information.

Methods: Cervical cancer patients were collected from the Surveillance, Epidemiology, and End Results (SEER) database. The Kaplan-Meier method estimated cancer-specific survival (CSS) and calculated the conditional CSS (C-CSS) at year y+x after giving x years of survival based on the formula C-CSS(y|x) =CSS(y+x)/CSS(x). y indicated the number of years of further survival under the condition that the patient was determined to have survived for x years. The study identified predictors by the least absolute shrinkage and selection operator (LASSO) regression and used multivariate Cox regression to demonstrate these predictors' effect on CSS and to develop a nomogram. Finally, the CSS possibilities predicted by the nomogram were brought into the C-CSS formula to create the CS-nomogram.

Results: A total of 18,511 patients aged <65 years with cervical cancer from 2004 to 2019 were included in this study. CS analysis revealed that the 15-year CSS increased year by year from the initial 72.6% to 77.8%, 84.5%, 88.8%, 91.5%, 93.5%, 94.8%, 95.7%, 96.4%, 97.3%, 98.0%, 98.5%, 99.1%, and 99.4% (after surviving for 1-13 years, respectively), and found that when survival exceeded 5-6 years, the risk of death from cervical cancer would be less than 5% in 10-15 years. The CS-nomogram constructed using tumor size, lymph node status, distant metastasis status, and histological grade showed strong predictive performance with a concordance index (C-index) of 0.805 and a stable area under the curve (AUC) between 0.795 and 0.816 over 15 years.

Conclusions: CS analysis in this study revealed the gradual improvement of CSS over time in long-term survived cervical cancer patients. We applied CS to the nomogram and developed a CS-nomogram successfully predicting individualized and real-time prognosis.

Citing Articles

Conditional survival estimates for ependymomas reveal the dynamic nature of prognostication.

Sun C, Yang Z, Gu Z, Huang H Discov Oncol. 2024; 15(1):460.

PMID: 39294501 PMC: 11411029. DOI: 10.1007/s12672-024-01275-8.


Conditional survival of patients with primary bone lymphoma of the spine: how survival changes after initial diagnosis.

Zheng G, Yang Z, Qian H, Huang H, Gu Z Front Oncol. 2024; 14:1356947.

PMID: 38751818 PMC: 11094224. DOI: 10.3389/fonc.2024.1356947.


Conditional survival analysis and dynamic prediction of long-term survival in Merkel cell carcinoma patients.

Zhang J, Xiang Y, Chen J, Liu L, Jin J, Zhu S Front Med (Lausanne). 2024; 11:1354439.

PMID: 38390567 PMC: 10881824. DOI: 10.3389/fmed.2024.1354439.

References
1.
Janssen-Heijnen M, Gondos A, Bray F, Hakulinen T, Brewster D, Brenner H . Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol. 2010; 28(15):2520-8. DOI: 10.1200/JCO.2009.25.9697. View

2.
Balachandran V, Gonen M, Smith J, DeMatteo R . Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015; 16(4):e173-80. PMC: 4465353. DOI: 10.1016/S1470-2045(14)71116-7. View

3.
Ni X, Ma X, Qiu J, Zhou S, Cheng W, Luo C . Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma. Ann Transl Med. 2021; 9(4):293. PMC: 7944266. DOI: 10.21037/atm-20-6201. View

4.
Nuersulitan R, Yang M, Mi L, Wu M, Liu X, Ping L . Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma. Cancer Manag Res. 2021; 13:6731-6741. PMC: 8405168. DOI: 10.2147/CMAR.S324543. View

5.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View